Jean Tang
Elite in Basal Cell Skin Cancer

Dr. Jean Tang

Dermatology
Stanford University Medical Center
450 Broadway St, 
Redwood City, CA 

Elite in Basal Cell Skin Cancer
Stanford University Medical Center
450 Broadway St, 
Redwood City, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jean Tang is a Dermatologist in Redwood City, California. Dr. Tang is rated as an Elite provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Nevoid Basal Cell Carcinoma Syndrome, Dystrophic Epidermolysis Bullosa, and Epidermolysis Bullosa.

Her clinical research consists of co-authoring 155 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 61 articles and participated in 3 clinical trials in the study of Basal Cell Skin Cancer.

Specialties
Dermatology
Licenses
Dermatology in CA
Hospital Affiliations
Stanford Health Care
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Stanford University Medical Center
450 Broadway St, Redwood City, CA 94063
Call: 650-723-6316
Other Locations
Stanford Hospital and Clinics
965 High St, Palo Alto, CA 94301
Call: 650-723-4000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Phase I/II, Closed Label, Randomized, Pilot Study for the Safety and Efficacy of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)
A Phase I/II, Closed Label, Randomized, Pilot Study for the Safety and Efficacy of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)
Enrollment Status: Completed
Publish Date: September 11, 2023
Intervention Type: Drug
Study Drug: TolaSure
Study Phase: Phase 1
A Phase 1/2A Single Center Trial of Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Using the Drug LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
A Phase 1/2A Single Center Trial of Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Using the Drug LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
Enrollment Status: Completed
Publish Date: August 22, 2023
Intervention Type: Biological
Study Drug: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets
Study Phase: Phase 1/Phase 2
VIITAL: A Phase 3 Study of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
VIITAL: A Phase 3 Study of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Enrollment Status: Completed
Publish Date: December 05, 2022
Intervention Type: Biological
Study Drug: EB-101
Study Phase: Phase 3
A Phase 2b Open-Label Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01 in Study PTR-01-002
A Phase 2b Open-Label Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01 in Study PTR-01-002
Enrollment Status: Completed
Publish Date: November 21, 2022
Intervention Type: Drug
Study Drug: PTR-01
Study Phase: Phase 2
A Phase 2 Open-Label Study of PTR-01 in Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Phase 2 Open-Label Study of PTR-01 in Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Enrollment Status: Completed
Publish Date: September 16, 2021
Intervention Type: Drug
Study Drug: PTR-01
Study Phase: Phase 2
A Phase 1/2 Randomized, Saline-Controlled, Single-Blind, Multiple Ascending Dose, Dose-Escalation, Multi-Center Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
A Phase 1/2 Randomized, Saline-Controlled, Single-Blind, Multiple Ascending Dose, Dose-Escalation, Multi-Center Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Enrollment Status: Completed
Publish Date: March 09, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Oral Arsenic Trioxide and Itraconazole for the Treatment of Patients With Advanced Basal Cell Carcinoma
Oral Arsenic Trioxide and Itraconazole for the Treatment of Patients With Advanced Basal Cell Carcinoma
Enrollment Status: Withdrawn
Publish Date: October 22, 2020
Intervention Type: Drug, Other
Study Phase: Early Phase 1
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Enrollment Status: Completed
Publish Date: April 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Case Study of the Effects of Topical Itraconazole on Pharmacodynamic Modulation of Hedgehog Target Gene Expression in Basal Cell Carcinomas in Patients
A Case Study of the Effects of Topical Itraconazole on Pharmacodynamic Modulation of Hedgehog Target Gene Expression in Basal Cell Carcinomas in Patients
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Other, Drug
Study Phase: Early Phase 1
An Open-label, Biomarker Study of Arsenic Trioxide for the Treatment of Patients With Basal Cell Carcinoma
An Open-label, Biomarker Study of Arsenic Trioxide for the Treatment of Patients With Basal Cell Carcinoma
Enrollment Status: Completed
Publish Date: June 08, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 9 Less Clinical Trials

154 Total Publications

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation.
Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation.
Journal: Journal of medical genetics
Published: June 01, 2025
View All 154 Publications
Similar Doctors
Elite in Basal Cell Skin Cancer
Dr. Sumaira Aasi
Dermatology
Elite in Basal Cell Skin Cancer
Dr. Sumaira Aasi
Dermatology

Stanford University Medical Center

450 Broadway St, 
Redwood City, CA 
 (0.1 miles away)
650-725-5272
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sumaira Aasi is a Dermatologist in Redwood City, California. Dr. Aasi is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Extramammary Paget Disease, and Melanoma.

Elite in Basal Cell Skin Cancer
Dr. Kerri Rieger
Dermatology
Elite in Basal Cell Skin Cancer
Dr. Kerri Rieger
Dermatology

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (3.9 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances

Kerri Rieger is a Dermatologist in Palo Alto, California. Dr. Rieger is rated as an Elite provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Mycosis Fungoides, Melanoma, and Sebaceous Adenoma.

Elite in Basal Cell Skin Cancer
Dr. Ervin Epstein
Dermatology
Elite in Basal Cell Skin Cancer
Dr. Ervin Epstein
Dermatology

Office

400 30th St Ste 205, 
Oakland, CA 
 (24.4 miles away)
510-444-8282
Languages Spoken:
English
See accepted insurances

Ervin Epstein is a Dermatologist in Oakland, California. Dr. Epstein is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Nevoid Basal Cell Carcinoma Syndrome, Basal Cell Skin Cancer, Intertrigo, and Solitary Fibrous Tumor.

VIEW MORE BASAL CELL SKIN CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tang's expertise for a condition
ConditionClose
  • Elite
  • Basal Cell Skin Cancer
    Dr. Tang is
    Elite
    . Learn about Basal Cell Skin Cancer.
    See more Basal Cell Skin Cancer experts
  • Dystrophic Epidermolysis Bullosa
    Dr. Tang is
    Elite
    . Learn about Dystrophic Epidermolysis Bullosa.
    See more Dystrophic Epidermolysis Bullosa experts
  • Epidermolysis Bullosa
    Dr. Tang is
    Elite
    . Learn about Epidermolysis Bullosa.
    See more Epidermolysis Bullosa experts
  • Nevoid Basal Cell Carcinoma Syndrome
    Dr. Tang is
    Elite
    . Learn about Nevoid Basal Cell Carcinoma Syndrome.
    See more Nevoid Basal Cell Carcinoma Syndrome experts
    • Advanced
    • Dominant Dystrophic Epidermolysis Bullosa
      Dr. Tang is
      Advanced
      . Learn about Dominant Dystrophic Epidermolysis Bullosa.
      See more Dominant Dystrophic Epidermolysis Bullosa experts
    • Dowling-Meara Epidermolysis Bullosa Simplex
      Dr. Tang is
      Advanced
      . Learn about Dowling-Meara Epidermolysis Bullosa Simplex.
      See more Dowling-Meara Epidermolysis Bullosa Simplex experts
    • Lamellar Ichthyosis
      Dr. Tang is
      Advanced
      . Learn about Lamellar Ichthyosis.
      See more Lamellar Ichthyosis experts
    • Melanoma
      Dr. Tang is
      Advanced
      . Learn about Melanoma.
      See more Melanoma experts
    • Milia
      Dr. Tang is
      Advanced
      . Learn about Milia.
      See more Milia experts
    • Squamous Cell Skin Carcinoma
      Dr. Tang is
      Advanced
      . Learn about Squamous Cell Skin Carcinoma.
      See more Squamous Cell Skin Carcinoma experts
    • Experienced
    • Acrogeria, Gottron Type
      Dr. Tang is
      Experienced
      . Learn about Acrogeria, Gottron Type.
      See more Acrogeria, Gottron Type experts
    • Actinic Keratosis
      Dr. Tang is
      Experienced
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Alopecia Areata
      Dr. Tang is
      Experienced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Athlete's Foot
      Dr. Tang is
      Experienced
      . Learn about Athlete's Foot.
      See more Athlete's Foot experts
    • Autosomal Recessive Hypotrichosis
      Dr. Tang is
      Experienced
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Bannayan-Riley-Ruvalcaba Syndrome
      Dr. Tang is
      Experienced
      . Learn about Bannayan-Riley-Ruvalcaba Syndrome.
      See more Bannayan-Riley-Ruvalcaba Syndrome experts
    View All 40 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.